Nobuaki Watanabe

3.2k citations

104 papers · 2.6k indexed · 1 hit paper · h-index 23

Molecular Biology top 10%
Oncology top 5%
Endocrinology, Diabetes and Metabolism top 2%
Pediatrics, Perinatology and Child Health top 5%
Surgery top 10%

Co-authors: Hitoshi Endou Takashi Sekine Makoto Hosoyamada Yoshikatsu Kanai Y Fujii-Kuriyama Kazuhiro Sogawa Makoto Otsuki Yoshihiko Funae
Topics: Diabetes Treatment and Management (19 papers)Metabolism, Diabetes, and Cancer (15 papers)Drug Transport and Resistance Mechanisms (15 papers)
Cited by: Pharmacology Endocrinology, Diabetes and Metabolism Oncology
Journals: Journal of Biological Chemistry Gastroenterology The Journal of Clinical Endocrinology & Metabolism
Partner nations: Japan Germany United States

In The Last Decade

Nobuaki Watanabe

98 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter

1997 527 citations Nobuaki Watanabe et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Nobuaki Watanabe

Since Specialization

Citations

This map shows the geographic impact of Nobuaki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuaki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuaki Watanabe more than expected).

Fields of papers citing papers by Nobuaki Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuaki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuaki Watanabe. The network helps show where Nobuaki Watanabe may publish in the future.

Co-authorship network of co-authors of Nobuaki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuaki Watanabe. A scholar is included among the top collaborators of Nobuaki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuaki Watanabe. Nobuaki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins 2023 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown),Eiko Suzuki,Masataka Oitate,Nobuaki Watanabe	1
2	Species differences between rats and primates (humans and monkeys) in complex cleavage pathways of DS-8500a characterized by 14C-ADME studies in humans and monkeys after administration of two radiolabeled compounds and in vitro studies 2022 ·Drug Metabolism and Pharmacokinetics ·(unknown),Akiko Watanabe,Manabu Kato,Hideyuki Shiozawa,Hideo Takakusa,Daisuke Nakai,(unknown),Nobuaki Watanabe	4
3	Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment 2022 ·Diabetes Therapy ·(unknown),Nobuaki Watanabe,(unknown),Isao Hayashi,Ryoya Komatsu,(unknown),Shingo Fujita,Megu Y. Baden,(unknown),Yukari Fujita,(unknown),Mitsuyoshi Takahara,Kenji Fukui,Hiromi Iwahashi,Junji Kozawa,Iichiro Shimomura	2
4	Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective NaV1.7 Inhibitor DS-1971a, a Mixed Substrate of Cytochrome P450 and Aldehyde Oxidase, Using Chimeric Mice With Humanized Liver 2022 ·Drug Metabolism and Disposition ·Daigo Asano,Kōichi Nakamura,Yumi Nishiya,Hideyuki Shiozawa,Hideo Takakusa,Takahiro Shibayama,Shinichi Inoue,(unknown),(unknown),(unknown),Nobuaki Watanabe,Kouichi Yoshinari	4
5	Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2) 2021 ·Advances in Therapy ·(unknown),Tomoyuki Katsuno,Toshihiko Shiraiwa,(unknown),Hyohun Park,Nobuaki Watanabe,Shizuka Kaneko,Jungo Terasaki,Toshiaki Hanafusa,Akihisa Imagawa,Iichiro Shimomura,Hiroshi Ikegami,Hidenori Koyama,Mitsuyoshi Namba,Jun‐ichiro Miyagawa	3
6	Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models 2020 ·Drug Metabolism and Disposition ·Makiko Yamada,Shinichi Inoue,Daisuke Sugiyama,Yumi Nishiya,Tomoko Ishizuka,Akiko Watanabe,Kengo Watanabe,Shinji Yamashita,Nobuaki Watanabe	15
7	Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization 2018 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Kunihiko Fujii,(unknown),Kousei Shimada,Yoshiyuki Onishi,Yumi Matsui,(unknown),Masanori Kuroha,(unknown),Kazushi Araki,Jun Ohsumi,(unknown),Nobuaki Watanabe,Hideki Yamamoto,Kazunori Fujimoto,(unknown),Makoto Mori,Jun Tanaka	7
8	Association of aging and blood profile with blood leukocyte population in Japanese Black beef steers 2011 ·(unknown),S. Komatsu,Nobuaki Watanabe,Takaaki ANDO,Hiromichi OHTSUKA,Masahiro Tomioka,K. Takagishi,(unknown)	0
9	Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes 2011 ·Journal of Biological Chemistry ·(unknown),Kazuishi Kubota,Masakazu Tamura,Shin‐ichi Inaba,(unknown),(unknown),Nobuaki Watanabe,Tatsuji Matsuoka,Futoshi Nara	13
10	Effectiveness of Odd Order Aspherical Surface 2007 ·(unknown),Masato Shibuya,(unknown),(unknown),Nobuaki Watanabe,Masayuki Yamamoto,Suezou Nakadate	4
11	Genetic Polymorphism of Aldehyde Oxidase in Donryu Rats 2007 ·Drug Metabolism and Disposition ·Kunio Itoh,(unknown),Takamitsu Sasaki,(unknown),Nobuaki Watanabe,Kiyoshi Nagata,Yasushi Yamazoe,Masahiro Hiratsuka,Michinao Mizugaki,Yorihisa Tanaka	16
12	Lack of dimer formation ability in rat strains with low aldehyde oxidase activity 2007 ·Xenobiotica ·Kunio Itoh,(unknown),(unknown),Kouki Hoshino,Nobuaki Watanabe,(unknown)	21
13	Lack of Formation of Aldehyde Oxidase Dimer Possibly Due to 377G>A Nucleotide Substitution 2007 ·Drug Metabolism and Disposition ·Kunio Itoh,(unknown),(unknown),(unknown),Nobuaki Watanabe,Yorihisa Tanaka	14
14	Rat strain differences in stereospecific 2‐oxidation of RS‐8359, a reversible and selective MAO‐A inhibitor, by aldehyde oxidase 2006 ·Biopharmaceutics & Drug Disposition ·Takamitsu Sasaki,(unknown),(unknown),Nobuaki Watanabe,Masahiro Hiratsuka,Michinao Mizugaki,Kunio Itoh,Yorihisa Tanaka	15
15	Contralateral Pterional Approach to a Giant Internal Carotid-Ophthalmic Artery Aneurysm: Technical Case Report 2001 ·Neurosurgery ·Kazuhiro Hongo,Nobuaki Watanabe,(unknown),Shigeaki Kobayashi	31
16	Purification and Characterization of the DNA-Binding Domain of BTEB, a GC Box-Binding Transcription Factor, Expressed in Escherichia coli 1996 ·The Journal of Biochemistry ·Yuko Kikuchi,Kazuhiro Sogawa,Nobuaki Watanabe,Akira Kobayashi,Y Fujii-Kuriyama	6
17	A novel cAMP‐dependent regulatory region including a sequence like the cAMP‐responsive element, far upstream of the human CYP21A2 gene 1993 ·European Journal of Biochemistry ·Nobuaki Watanabe,(unknown),Jun-ichi Fujisawa,Mitsuaki Yoshida,Yoshiaki Fujii‐Kuriyama	20
18	Structures of regulatory regions in the human cytochrome P‐450_scc (desmolase) gene 1991 ·European Journal of Biochemistry ·Hideshi Inoue,Nobuaki Watanabe,Yujiro Higashi,Yoshiaki Fujii‐Kuriyama	45
19	Effect of glucagon-(1–21)-peptide on secretin-stimulated pancreatic exocrine secretion in anesthetized dogs 1989 ·Life Sciences ·H. Itoh,Tatsuo Matsuyama,Mitsuyoshi Namba,Nobuaki Watanabe,Ryoya Komatsu,Norio Kôno,Seiichiro Tarui	5
20	Insulin Action in Isolated Rat Soleus Muscles: Insulin Binding and Insulin Stimulation of 2-deoxyglucose (2 DOG) Uptake 1984 ·Hiroshi Maegawa,Masashi Kobayashi,(unknown),Nobuaki Watanabe,Yukio Shigeta	1

About Nobuaki Watanabe

Nobuaki Watanabe is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 104 papers that have together received 2.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (15 papers) and Drug Transport and Resistance Mechanisms (15 papers). The work is most often cited by research in Pharmacology (341 citations), Endocrinology, Diabetes and Metabolism (481 citations) and Oncology (769 citations). Nobuaki Watanabe has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hitoshi Endou, Takashi Sekine, Makoto Hosoyamada, Yoshikatsu Kanai, Y Fujii-Kuriyama, Kazuhiro Sogawa, Makoto Otsuki, Yoshihiko Funae, Osamu Gotoh and Masatsugu Ema. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact